Axa
SGYP

Axa’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Axa’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-220,380
Closed -$1.25M – 1473
2015
Q4 		$1.25M Buy
220,380
+102,920
+88% +$627K 0.01% 870
2015
Q3 		$623K Buy
+117,460
New +$909K ﹤0.01% 1005

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Axa's SGYP Position: Q1 2016 in Review

Axa sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2016, closing a stake of 220,380 shares — an estimated $1.25M sold.

Axa first reported a position in SGYP in Q3 2015 and held it in 2 quarters. The position peaked at $1.25M in Q4 2015. 128 funds tracked by Wall St. Rank hold SGYP as of Q1 2016.

  • Axa reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2016 after selling out during the quarter.
  • Axa sold 220,380 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2016, an estimated $1.25M.
  • Axa first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2015 and held it in 2 quarters.
  • Axa's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.25M in Q4 2015.
  • 128 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2016.

Based on Axa's 13F filing for Q1 2016, filed 13 May 2016.